Dimitrios Varrias, MD
Clinical FellowAbout
Research
Publications
2026
Long‐Term Outcomes After Catheter Ablation: A 42‐Month Longitudinal Study From the ITHACA‐Database
Varrias D, Coleman K, Leavitt J, Yu K, Ismail H, Chinitz J, Mitra R, Kowalski M, Skipitaris N, Epstein L, Mountantonakis S, Investigators I. Long‐Term Outcomes After Catheter Ablation: A 42‐Month Longitudinal Study From the ITHACA‐Database. Journal Of Cardiovascular Electrophysiology 2026, 37: 1268-1275. PMID: 41981863, DOI: 10.1111/jce.70345.Peer-Reviewed Original ResearchClinical predictors of long-term atrial fibrillation recurrence post catheter ablation: an ITHACA-database analysis.
Leavitt J, Varrias D, Gasparis C, Wolf E, Zafeiropoulos S, Zimmer A, Epstein L, Coleman K, Mountantonakis S. Clinical predictors of long-term atrial fibrillation recurrence post catheter ablation: an ITHACA-database analysis. Journal Of Invasive Cardiology 2026, 38 PMID: 41538776, DOI: 10.25270/jic/25.00273.Peer-Reviewed Original Research
2025
Long-Term Outcomes Beta-Blocker Use and Permanent Pacing in Patients With Heart Failure Preserved Ejection Fraction
Gabriels J, Coleman K, Fishbein J, Cunn G, Bekiaridou A, Varrias D, Sharma N, Mokhtari M, George R, Brennan C, Gandomi A, Vullaganti S, Epstein L, Mountantonakis S. Long-Term Outcomes Beta-Blocker Use and Permanent Pacing in Patients With Heart Failure Preserved Ejection Fraction. JACC Advances 2025, 5: 102425. PMID: 41401684, PMCID: PMC12769800, DOI: 10.1016/j.jacadv.2025.102425.Peer-Reviewed Original ResearchLeveraging Implantable Cardiac Defibrillator Remote Transmissions to Predict the Occurrence of Atrial Fibrillation
Scheid M, Coleman K, Mullane S, Varrias D, Mountantonakis E, Husk G, Bhasin K, Skipitaris N, Epstein L, Zanos T, Mountantonakis S. Leveraging Implantable Cardiac Defibrillator Remote Transmissions to Predict the Occurrence of Atrial Fibrillation. Journal Of Cardiovascular Electrophysiology 2025, 36: 2903-2909. PMID: 40916235, DOI: 10.1111/jce.70072.Peer-Reviewed Original ResearchAction PotentialsAgedAtrial FibrillationDecision Support TechniquesDefibrillators, ImplantableElectric CountershockFemaleHeart FailureHeart RateHumansMachine LearningMaleMiddle AgedPredictive Value of TestsPrimary PreventionProspective StudiesRemote Sensing TechnologyReproducibility of ResultsRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeIschaemic cerebrovascular events post-atrial fibrillation catheter ablation: a descriptive report on the ITHACA database
Leavitt J, Nunez-Baez S, Varrias D, Kleiman J, Gasparis C, Coleman K, Mountantonakis S. Ischaemic cerebrovascular events post-atrial fibrillation catheter ablation: a descriptive report on the ITHACA database. European Heart Journal - Quality Of Care And Clinical Outcomes 2025, 12: 429-430. PMID: 40853222, DOI: 10.1093/ehjqcco/qcaf094.Peer-Reviewed Original ResearchThe Impact of Diagnostic Code and Inclusion Period on Clinical Outcomes in ATTR Cardiomyopathy
Lee P, Chi K, Lin Y, Varrias D, Patel S. The Impact of Diagnostic Code and Inclusion Period on Clinical Outcomes in ATTR Cardiomyopathy. JACC Advances 2025, 4: 101918. PMID: 40713144, PMCID: PMC12418417, DOI: 10.1016/j.jacadv.2025.101918.Commentaries, Editorials and LettersDifferences in intravascular hemolysis between 2 technologies for pulse field ablation of atrial fibrillation
Mountantonakis S, Beccarino N, Goyal A, Ferrick N, Varrias D, Baez S, Calvo A, Kruger S, Alshenawy M, Leavitt J, Sharma N, Jia K, Vele O, Abrams M, Choudry S, Krumerman A, Skipitaris N, Bhasin K, Coleman K. Differences in intravascular hemolysis between 2 technologies for pulse field ablation of atrial fibrillation. Heart Rhythm 2025, 23: e217-e219. PMID: 40675312, DOI: 10.1016/j.hrthm.2025.07.018.Peer-Reviewed Original ResearchAnticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage A Meta-Analysis of Randomized Trials
Chi K, Chang Y, Lee P, Rossi R, Lin Y, Akman Z, Varrias D, Damluji A, Nanna M. Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage A Meta-Analysis of Randomized Trials. Journal Of The American College Of Cardiology 2025, 86: 287-290. PMID: 40701674, PMCID: PMC12758899, DOI: 10.1016/j.jacc.2025.04.069.Peer-Reviewed Original ResearchCatheter-Based Therapies in Acute Pulmonary Embolism—Mortality and Safety Outcomes: A Systematic Review and Meta-Analysis
Zoumpourlis P, Mangeshkar S, Chi K, Varrias D, Spanos M, Fahimuddin M, Langston M, Khan U, Grushko M, Singh P, Sokol S. Catheter-Based Therapies in Acute Pulmonary Embolism—Mortality and Safety Outcomes: A Systematic Review and Meta-Analysis. Journal Of Clinical Medicine 2025, 14: 4167. PMID: 40565913, PMCID: PMC12194266, DOI: 10.3390/jcm14124167.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsGLP-1 RA Use and Major Adverse Cardiovascular Events in Patients With Monoclonal Gammopathy of Undetermined Significance
Chi K, Song J, Desphande S, Lee P, Soni A, Gonzales-Uribe A, Lessa Y, Morgan A, Chang Y, Lin Y, Akman Z, Nouri A, Rossi R, Babapour G, Varrias D, Parker T, Baldassarre L, Jha A, Muchtar E, Hull S, Kwan J, Nanna M. GLP-1 RA Use and Major Adverse Cardiovascular Events in Patients With Monoclonal Gammopathy of Undetermined Significance. JAMA Network Open 2025, 8: e2517541. PMID: 40587132, PMCID: PMC12210086, DOI: 10.1001/jamanetworkopen.2025.17541.Peer-Reviewed Original Research